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IN a careful examination ofthe long-term effects oflarge doses oflead, Zollinger
(1953) described thetumours ofthe kidney in rats induced byrepeated injection of
lead phosphate. This finding has been confirmed byWalpole (personal communica-
tion in Matthews and Walpole, 1958) who also obtained tumours in the kidney by
injection oflead phosphate. The tumours were similar to those caused by admini-
stration of 4-amino-5-fluorobiphenyl (Matthews and Walpole, 1958).
Van Esch, van Genderen and Vink (1959, personal communication) fed rats on
a diet containing 1 per cent of basic lead acetate over a period of two years. At
the end ofthis period the surviving rats were killed and many were found to have
malignant tumours ofthe kidney. That rats should survive for two years on a diet
containing 1 per cent lead acetate is surprising, in view of the known toxicity of
lead compounds. In this paper, the findings of van Esch, van Genderen and Vink
(1959, personal communication) are confirmed.
Fairhall and Miller (1941) had previously carried out experiments with much
lower concentrations oflead. They maintained rats on diets containing 0.1 per cent
oflead arsenate and 0-1 per centlead carbonate fortwoyears. Themortalityin the
group fed the lead carbonate was almost the same as in the controls. At the end of
the two year period, the kidneys ofthe rats were found to have many swollen cells
with large vesicular nuclei and brown granules; the latter were most prominent in
the proximal convoluted tubules, but no neoplasms were reported. The concentra-
tion oflead in the kidney was higher than in the liver but lower than in bone.
Lead compounds are known to cause increased excretion of porphyrins by
interfering with haemoglobin metabolism. As the porphyrins pass through the
kidney they might be the immediate carcinogen, rather than the administered lead.
Lead is deposited in bones, so that if the lead itself were carcinogenic then bone
tumourswouldbeexpected. Thehypothesisthatporphyrinsmightbetheimmediate
carcinogens in the kidney was tested by administering allylisopropylacetylcar-
bamide (Sedormid), which also causes porphyrinuria, to rats. The porphyrin
concentration in the urine of rats dosed with lead acetate, sedormid and other
substances known to cause porphyrinuria was measured.
Experimental
Twogroups of20 male 10-week-old Wistar ratswere maintained on a 20 per cent
protein diet of the following composition; white flour, 68-7 per cent ; casein,
11-5 per cent; milk powder, 8 per cent; margarine, 3*3 per cent; chalk, 1-3 per
cent; salt mixture (Glaxo Laboratories), 0 8 per cent; " Bemax ", 2 5 per cent;284 E. BOYLAND, C. E. DUKES, P. L. GROVER AND B. C. V. MITCHLEY
cod liver oil, 1-5 per cent ; dried yeast, 2-4 per cent. Lead acetate (1 per cent w/w)
was mixed with the dry diet for one group and sedormid (0.5 per cent w/w) with
that for the other group. The diets were mixed to a dough with water before
feeding and drinking water was supplied ad libitum. The lead acetate and sedormid
containing diets were fed at the rate of20 g. ofdry diet/rat/day for the first month,
30 g./rat/day for the second month and then 40 g./rat/day for the succeeding 10
months. After 1 year the lead and sedormid diets were replaced by the basic 20
per cent protein diet. The rats were individually weighed at regular intervals and
on both the lead and sedormid diets showed a steady increase in weight from 200 g.
atthe start ofthe experiment to 600-800g. after 1 year. Theanimals werepalpated
regularly and were killed when they appeared to be ill with marked loss ofweight,
or when a tumour was palpable.
TABLE I.-Lead Acetate Feeding Experiment
Twenty male rats fed a 20 per cent protein diet containing 1 per cent lead
acetate for up to one year
Survival time
in days
77
105
126
146
331
335
335
335
350
358
368
436
456
476
484
519
543
582
606
629
Pathology
Hydronephrosis.
Pyelonephritis.
Decomposed.
Nothing abnormal detected.
Right kidney-renal carcinoma.
Bilateral renal tumours with adrenal involvement.
Bilateral cuboidal cell carcinoma of kidney.
Bilateral cuboidal cell carcinoma of kidney.
Nothing abnormal detected.
Bilateral cuboidal cell carcinoma of kidney.
Right kidney cuboidal cell carcinoma.
Papillary carcinoma ofright kidney.
Bilateral renal cuboidal cell carcinoma.
Renal cuboidal cell carcinoma ?, bilateral.
Bilateral renal cuboidal cell carcinoma.
Bilateral renal carcinoma (cuboidal cell).
Bilateral renal cuboidal cell carcinoma.
Papillary carcinoma-bilateral.
Renal carcinoma-bilateral: histologically variable.
Bilateral renal carcinoma.
EXPLANATION OF PLATES
FIG. 1.-" Cystic nephritis " in rat fed for one year on sedormid diet. Death 18 months
after commencement of experiment. No tumours.
FIG. 2.-Early focus ofcarcinoma (marked by arrow) in kidney ofrat fed for 11 months on lead
acetate diet. " Cystic nephritis " also present.
FIG. 3.-Large focus of carcinoma in kidney of rat fed for one year on lead acetate diet.
Severe " cystic nephritis " also present. Rat died 19 months after commencement of
experiment.
FIG. 4.-Two large carcinomas in kidney of rat fed for one year on lead acetate diet. Rat
died 15 months after commencement of experiment.
FIG. 5.-Margin of solid cuboidal cell renal carcinoma in rat fed for one year on lead acetate
diet. X 90.
FIG. 6.-Higher magnification of tumour illustrated in Fig. 5. x 590.
FIG. 7.-Tubular pattern developing in cuboidal cell renal carcinoma. Rat died 14 months
after commencement of lead acetate diet. x90.
FIG. 8.-Papillary pattern at margin of large renal carcinoma in rat 15 months after com-
mence of experiment. X90.BRITISH JOURNAL OF CANCER.
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TABLE II.-Sedormid Feeding Experiment
Twenty male rats fed a 20 per cent protein diet containing 0-5 per cent
sedormid for up to one year
Survival time
in days
104
137
165
345
345
363
373
464
488
506
506
534
569
595
596
616
679
692
702
702
Pathology
Pyelonephritis.
Nothing abnormal detected.
Interstitial nephritis with toxic liver.
Hyaline casts-kidney. Fatty liver.
Killed, worm infection. No neoplasm.
Abscess in lung. Fatty liver. Cystic dilatation of tubules.
Bilateral hydronephrosis and pyelonephritis.
Nothing abnormal detected.
Invasive carcinoma of kidney-small foci.
Cystic nephritis.
Nothing abnormal detected.
Nephritis.
Chronic nephritis.
Nephritis.
Hydronephritis.
Nephritis.
TABLE III.-Excretion of Urinary Coproporphyrin III by Male Rate
Treatment
Untreated controls
Lead acetate (1% of diet)
16 days after cessation of lead diet
Sedormid (0.5% of diet)
3 days after cessation of sedormid diet .
1,4-Dihydro-2,4,6-trimethyl-3,5-dicarbethoxypyridine
(a) 0.5% of diet
(b) 1-0% of diet
Ethyl methane sulphonate (200 mg./kg.) by subcutaneous injec-
tion (mean for 3 days after single injection)
4-Fluoro-4'-aminodiphenyl (100 mg./kg.) by subcutaneous in-
jection (mean for 3 days after a single injection)
Coproporphyrin
(eIzg./2 rats/day)
Young rats Adult rats
(200 g.) (650 g.)
5*6 12*6
- 93
- 33
233
30
14-6
20-0 -
86-6
8-4
Porphyrin excretion
Urine was collected from pairsofmaleratshousedinall-glassmetabolism cages,
and the urinary coproporphyrin III determined spectrophotometrically (Riming-
ton, 1958). The results ofthese determinations are given in Table III.
Description ofrenal lesions caused by lead acetate and sedormid
Both lead acetate and sedormid given orally to rats caused chronic cystic
nephritis; in the lead acetate animals this was followed by neoplasms, whereas in
the sedormid animals it was not. In the lead acetate series 16 out of 20 animals
lived for 320 days or more and 15 of these ultimately developed kidneytumours,
either adenomas or carcinomas; the tumours were often multiple and bilateral.
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In the sedormid series only one neoplastic renal lesion was found, but this was
an epidermoid carcinoma of the renal pelvis at an early stage of development and
not a tumour of the renal parenchyma. Another animal had an interstitial cell
tumour ofthe testicle, but both these lesions were probably incidental findings and
not related to the experiment.
After a period ofabout 6 months all the rats in the experiments, whether given
lead acetate or sedormid, developed a lesion which we have called chronic cystic
nephritis. The kidneys were slightly enlarged, appeared granular and on section
were found to contain innumerable small cysts (Fig. 1). These were lined with
cuboidal orflattened epithelium and often contained hyaline eosinophilicmaterial.
The lesion was obviously due to a cystic dilatation ofthe renal tubules accompanied
by a slight degree of interstitial fibrosis. The glomeruli and blood vessels did not
appear to be affected.
The animals were kept alive as long as possible to see how many eventually
developed tumours, so that the initial stages of these renal lesions were not seen,
but early effects on the kidney of ingested lead have been previously recorded.
Finner and Calvery (1939) made a series of pathological examinations on groups
ofrats receiving diets containing different lead compounds, including lead acetate.
They found that the kidneys showed marked irregularity ofthe tubular epithelium
with hypertrophy of the nuclei, some of which contained eosinophilic inclusion
bodies similar to those known to occur in the kidneys in cases of lead poisoning in
man. Pardoe (1952) found that during the first three months of treatment with
lead, microscopic examination revealed little change in the kidneys of rats, but
after 4 to 5 months degenerative changes were evident in the renal tubules,
particularly in the deep cortex towards the boundary zone. The second convoluted
tubules were also affected and often dilated and lined by flattened regenerating
epithelium. The blood vessels and glomeruli appeared normal and no changes were
found in the interstitial tissue apart from focal infiltration with small lymphocytes
in relation to the most damaged tubules.
In the present experiment, 4 of the 20 rats fed on the lead acetate diet died
within 6 months and showed degenerative changes in the kidneys but no neoplasms.
The first renal tumour was found in a rat which had been fed the lead acetate diet
for 11 months. The animal was killed because it was obviously ill, and at post-
mortem examination a small solid nodule was noticed in the right kidney. On
section this was found to be an early focus of cuboidal cell carcinoma (Fig. 2).
Four more rats which had received the lead acetate diet for 11 months were
killed and dissected within the next few days and in 3, renal tumours were found.
Eleven of the 20 rats survived for more than 12 months. These were killed
when a tumour could be palpated or when the animal appeared to be ill, and renal
carcinoma was found in each of these eleven animals. Two ofthese are illustrated
in Fig. 3 and Fig. 6. The tumours were often bilateral and associated with small
adenomas, hyperplastic foci and nodules of regenerating tubular epithelium. The
smaller neoplastic lesions were usually solid collections ofcuboidal cells (Fig. 5 and
Fig. 6) but the larger tumours tended to develop a tubular (Fig. 7) or papillary
pattern (Fig. 8) with vacuolated cells similar to those of human renal carcinomas.
DISCUSSION
The experiments extend the findings of Zollinger (1953) and Matthews and
Walpole (1958),andconfirmthoseofvanEsch,vanGenderenandVink (1959,personalRAT RENAL TUMOURS INDUCED BY LEAD
communication) that ingested lead induces cancer ofthe kidney in rats. The signi-
ficance ofthe results in relation to other causes ofrenal tumours has been discussed
elsewhere (Dukes, 1961). They leave open the question whether the actual carci-
nogen is a lead derivative or porphyrin (or possibly a lead porphyrin). The failure
ofsedormid to induce kidney tumours might be due to different types ofporphyria
being caused by lead salts, and sedormid. In another investigation Connell (1961,
personal communication) treated micewithethyl methanesulphonate and obtained
a number of kidney tumours. The injection of ethyl methanesulphonate into rats
caused marked porphy-rinuria (Table III) so that in this case the actual carcinogen
could be a porphyrin. Treatment with 4'-amino-4-fluorobiphenyl did not increase
porphyrin excretion, but with this compound the actual carcinogen is probably an
excreted metabolite-either an aminophenol or aryl hydroxylamine derivative.
Although lead salts and sedormid both induce porphyrinuria the modes of
action are probably different. Sedormid appears to inhibit the conversion of
porphyrins into catalase and haemoglobin (Schmid and Schwarz, 1956) so that the
synthesised porphyrins are not utilised but excreted. On the other hand, lead
appears to cause breakdown ofhaemoglobin and increase in porphyrins in this way
(cf. Goldblatt, 1955). The immediate carcinogen might be a lead porphyrin. Other
substances which induce porphyria are being examined for carcinogenic activity.
Althoughthe carcinogenicactivity ofleadphosphate andlead acetatehave been
clearly demonstrated, tumours have only been induced with large doses of the
compounds. Tests should be carried out with lead salts at lower levels and with
derivatives of other metals, particularly tin, antimony and zinc. Investigations
which might provide evidence that exposure to lead presents an occupational
cancer hazard for man have not been made, but mortality from renal cancer has
been increasing in males during th past decades in England and Wales (Case, 1956).
The increase could be due to some environmental factor.
Because the repeated demonstration that the administration of lead salts
induces renal cancer inrats, the possiblitythat lead derivatives have causedcancer
in man should be examined. The fact that the same carcinogen can induce cancer
at different sites in different species (e.g. benzidine causes bladder cancer in man
and liver cancer in rats) indicates that tumours of all sites should be looked for in
men who have been exposed to lead. As lead derivatives damage bone marrow they
might induce leukaemia and it would be important to look for blood abnormalities
as well as tumours of all sites in an epidemiological study.
The amount of lead in road dust and in the air of towns has increased greatly
since lead tetraethyl has been added to petrol. Thus, the lead content ofthe air of
Zurich has increased from 1.4 4tg. per m3 in 1949-50 (before lead tetraethyl was
used) to 4-5jtg. per m3 in 1960-61 (Eidg. Bleibenzin Kommission, 1961). People
living in cities absorb 20-301ag. oflead per day from their inspired air. This is small
compared with the 200-300 ,tg. per day of lead which is the usual intake of lead
from food for Europeans.
SUMMARY
1. Twenty male rats fed on a diet containing 1 per cent lead acetate for one year
excreted porphyrin and developed cystic nephritis. Of 16 rats which survived
320 days, 15 were found to have eitheradenomas oradenocarcinomas ofthe kidney.
2. Twenty male rats fed on a diet containing sedormid for one year excreted
large quantities of porphyrin and also developed cystic nephritis. No tumours of
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the kidney parenchyma occurred in them but an early form of transitional cell
carcinoma of the renal pelvis was noticed in one animal.
We are indebted to Dr. J. Marks ofRoche Products Ltd., Welwyn Garden City,
for a gift of sedormid used in the experiments. This investigation has been sup-
ported by grants to the Chester Beatty Research Institute (Institute of Cancer
Research: Royal Cancer Hospital) from the Medical Research Council, the British
Empire Cancer Campaign, the Anna Fuller Fund, and the National Cancer Insti-
tute of the National Institutes of Health, U.S. Public Health Service.
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